BTA test and voided urine cytology in the diagnosis and management of cancer of the bladder;Wertigkeit von BTA-test und urinzytologie bei der diagnostik und nachsorge des harnblasenkarzinoms

Aktuelle Urologie

Volumn 29, Issue 2, 1998, Pages 57-61

  Leyh, H ^a,d   Hall, R ^b   Mazeman, E ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIV LILLE   (France)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bladder carcinoma; BTA test; Urine cytology

Indexed keywords

EID: 0032390655     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065263     Document Type: Article

References (12)

1. Badalament RA, Hermansen DK, Kimmel M, Gay H, Herr HW, Fair WR, Whitmore WF Jr., Melamed MR. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60:1423-7
2. th Edition. Philadelphia: Saunders; 1992. pp 1084-1158
3. Murphy WM. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol. 1990;21:886-96
4. Wiener HG, Vooijs GP, van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993;37:163-9
5. Schork MA, Williams GW. Number of Observations Required for the Comparison of Two Correlated Proportions. University of Michigan, Department of Biostatistics, Technical Report Series No.9, 1976
6. D'Hallewin M-A, Baert L. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 1995;155:475-6
7. Ianari A, Strenberg CN, Rossetti A, van Rijn A, Deidda A, Giannarelli D, Pansadoro V. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder. Urology 1997;49:786-9
8. Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA. Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995;154:379-84
9. Kirollos MM, McDermott S, Bradbrook RA. The performance characteristics of the bladder tumour antigen test. Br J Urol 1997;80:30-4
10. Johnston B, Morales A, Emerson L, Lundie M. Rapid detection of bladder cancer: a comparative study of point of care tests. J Urol 1997;158:2098-2101
11. Murphy WM, Rivera-Ramirez I, Medina CA, Wright NJ, Wajsman Z. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. J Urol 1997;158:2102-06
12. Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, de Vere White R, Sheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak GW, Lamm DL, Johnson RD, Henderson M, Adams G, Blumenstein BA, Thoelke KR, Pfalzgraf RD, Murchison HA, Brunelle SL. Improved detection of recurrent bladder cancer using the Bard BTA stat test. Urology 1997;50:349-53